MEDIMAPS GROUP Raises $20 Million to Expand and to Commercialize AI Product Portfolio for Bone Health Assessment Utilizing Routine Medical Images
Summary
This technology is applied to a wide spectrum of image modalities and resolution thereby providing solutions ranging from opportunistic X-ray based screening, to patient risk profiling, and to presurgical assessment. Our passion is to improve patient care and to empower doctor decisions by developing innovative simple solutions to complex medical needs for the benefit of healthy aging.” Swisscanto Invest is the asset management arm of the Zürcher Kantonalbank group, one of Switzerlands largest fund providers, developing high-quality investment and pension solutions for private investors, companies and institutions. The Swisscanto Growth Fund provides capital to companies in the expansion phase active in the information, communication, technology (ICT) as well as in the healthcare sectors, mainly in Switzerland and opportunistically abroad. The Swisscanto Growth Fund aims at creating added value during the market penetration by supporting its portfolio companies with capital, know-how and access to international partners for further expansion until a successful exit. Medimaps Group’s medical imaging software applications based on patented multi-purpose technology with artificial intelligence capabilities provide healthcare solutions that fit seamlessly into the workflow for the benefit of the patient.